This is a Validated Antibody Database (VAD) review about human ABCB1, based on 77 published articles (read how Labome selects the articles), using ABCB1 antibody in all methods. It is aimed to help Labome visitors find the most suited ABCB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ABCB1 synonym: ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (G-1)
  • western blot knockout validation; human; fig 2
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, SC-13131) was used in western blot knockout validation on human samples (fig 2). Am J Transl Res (2016) ncbi
Invitrogen
mouse monoclonal (C219)
  • immunohistochemistry knockout validation; mouse; loading ...
  • western blot knockout validation; mouse; loading ...
Invitrogen ABCB1 antibody (Thermo Scientific, MA1-26528) was used in immunohistochemistry knockout validation on mouse samples and in western blot knockout validation on mouse samples . Neurotrauma Rep (2020) ncbi
Abcam
domestic rabbit monoclonal (EPR10364-57)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 3c
  • western blot knockout validation; mouse; loading ...; fig 3b
Abcam ABCB1 antibody (AbCam, ab170904) was used in immunohistochemistry knockout validation on mouse samples (fig 3c) and in western blot knockout validation on mouse samples (fig 3b). Neurotrauma Rep (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-11)
  • immunohistochemistry; human; loading ...; fig s1a
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in immunohistochemistry on human samples (fig s1a). J Cell Mol Med (2021) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:100; loading ...; fig 7i
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz Biotechnology, sc-55510) was used in western blot on human samples at 1:100 (fig 7i). Cancers (Basel) (2021) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:1000; loading ...; fig 2
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in western blot on human samples at 1:1000 (fig 2). Onco Targets Ther (2020) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:200; loading ...; fig 6a
In order to started the linkage of HFE genotype and exosome phenotype in cancer, Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in western blot on human samples at 1:200 (fig 6a). Biochim Biophys Acta Gen Subj (2017) ncbi
mouse monoclonal (3H2833)
  • western blot; human; 1:1000; loading ...; fig 4a
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-71557) was used in western blot on human samples at 1:1000 (fig 4a). Apoptosis (2017) ncbi
mouse monoclonal (G-1)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-13131) was used in western blot on human samples (fig 1b). Exp Mol Med (2017) ncbi
mouse monoclonal (G-1)
  • western blot knockout validation; human; fig 2
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, SC-13131) was used in western blot knockout validation on human samples (fig 2). Am J Transl Res (2016) ncbi
mouse monoclonal (D-11)
  • western blot; human; fig 4
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in western blot on human samples (fig 4). Onco Targets Ther (2016) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:500; fig 4
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in western blot on human samples at 1:500 (fig 4). Evid Based Complement Alternat Med (2016) ncbi
mouse monoclonal (D-11)
  • western blot; human; fig 4A
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, SC-55510) was used in western blot on human samples (fig 4A). PLoS ONE (2015) ncbi
mouse monoclonal (D-11)
  • western blot; human; 1:500; loading ...; fig 5aa
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in western blot on human samples at 1:500 (fig 5aa). PLoS ONE (2015) ncbi
mouse monoclonal (G-1)
  • western blot; human; fig 5
Santa Cruz Biotechnology ABCB1 antibody (santa Cruz, SC-13131) was used in western blot on human samples (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (G-1)
  • western blot; human; fig 3
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, SC-13131) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (G-1)
  • western blot; human; 1:1000; fig 2
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz Biotechnology, sc-13131) was used in western blot on human samples at 1:1000 (fig 2). Cancer Gene Ther (2015) ncbi
mouse monoclonal (D-11)
  • immunohistochemistry - paraffin section; human; fig 1
  • western blot; human; 1:200; fig 5
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in immunohistochemistry - paraffin section on human samples (fig 1) and in western blot on human samples at 1:200 (fig 5). Mol Med Rep (2015) ncbi
mouse monoclonal (G-1)
  • western blot; human; 1:1000; fig 1
In order to characterize multidrug-resistant cancer cells and attenuation of proteasome inhibitor-mediated apoptosis by ABCB1 expression and Wnt pathway activation, Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-13131) was used in western blot on human samples at 1:1000 (fig 1). Cancer Biol Ther (2015) ncbi
mouse monoclonal (D-11)
  • immunohistochemistry; human; loading ...; fig 1
  • western blot; human; loading ...; fig 2B
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 2B). Oncotarget (2015) ncbi
mouse monoclonal (G-1)
  • western blot; human
In order to study the role of Wnt5A signaling in cancer drug resistance, Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz Biotechnology, sc-13131) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (D-11)
  • western blot; human; fig 4
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in western blot on human samples (fig 4). Oncol Rep (2015) ncbi
mouse monoclonal (D-11)
  • western blot; human; fig 4c
Santa Cruz Biotechnology ABCB1 antibody (SantaCruz, sc-55510) was used in western blot on human samples (fig 4c). Oncotarget (2014) ncbi
mouse monoclonal (D-11)
  • immunocytochemistry; human; 1:500
  • western blot; human; 1:100
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-55510) was used in immunocytochemistry on human samples at 1:500 and in western blot on human samples at 1:100. Mol Pharm (2014) ncbi
mouse monoclonal (G-1)
  • western blot; human
Santa Cruz Biotechnology ABCB1 antibody (Santa Cruz, sc-13131) was used in western blot on human samples . Anat Rec (Hoboken) (2014) ncbi
Invitrogen
mouse monoclonal (C219)
  • immunohistochemistry knockout validation; mouse; loading ...
  • western blot knockout validation; mouse; loading ...
Invitrogen ABCB1 antibody (Thermo Scientific, MA1-26528) was used in immunohistochemistry knockout validation on mouse samples and in western blot knockout validation on mouse samples . Neurotrauma Rep (2020) ncbi
mouse monoclonal (C219)
  • western blot; mouse; 1 ug/ml; fig 1c
Invitrogen ABCB1 antibody (ThermoFisher, MA1?C26528) was used in western blot on mouse samples at 1 ug/ml (fig 1c). Neurobiol Dis (2020) ncbi
mouse monoclonal (F4)
  • immunocytochemistry; human; 1:100; loading ...; fig 4b
Invitrogen ABCB1 antibody (Thermo Fisher, MA5-13854) was used in immunocytochemistry on human samples at 1:100 (fig 4b). elife (2020) ncbi
mouse monoclonal (C219)
  • immunohistochemistry - paraffin section; human; 1:20; loading ...; fig s4
Invitrogen ABCB1 antibody (Thermo Fisher Scientific, MA1-26528) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig s4). Epilepsia (2018) ncbi
mouse monoclonal (C219)
  • immunohistochemistry; fruit fly ; fig s2d
Invitrogen ABCB1 antibody (ThermoFisher, MA1-26528) was used in immunohistochemistry on fruit fly samples (fig s2d). Cell (2018) ncbi
mouse monoclonal (UIC2)
  • flow cytometry; dogs; loading ...; fig 5
In order to evaluate the use of valspodar to treat canine B-cell lymphoma, Invitrogen ABCB1 antibody (EBioscience, 17-2439-42) was used in flow cytometry on dogs samples (fig 5). F1000Res (2015) ncbi
mouse monoclonal (C219)
  • immunohistochemistry - frozen section; rat; fig 2c
  • western blot; rat; 1:75; fig 2b
In order to develop a method to increase the intestinal transport of octreotide, Invitrogen ABCB1 antibody (Thermo Fisher, MA1-26528) was used in immunohistochemistry - frozen section on rat samples (fig 2c) and in western blot on rat samples at 1:75 (fig 2b). Exp Ther Med (2016) ncbi
mouse monoclonal (C219)
  • western blot; mouse; fig 1A
In order to generate a shortened mutant allele of P-glycoprotein to determine its structure, Invitrogen ABCB1 antibody (Invitrogen, C219) was used in western blot on mouse samples (fig 1A). J Biol Chem (2017) ncbi
mouse monoclonal (C219)
  • western blot; mouse; 1 ug/ml; loading ...; fig 2a
In order to assess the effect of caloric restriction on neurovascular functions, Invitrogen ABCB1 antibody (ThermoFisher, MA1-26528) was used in western blot on mouse samples at 1 ug/ml (fig 2a). Aging (Albany NY) (2016) ncbi
mouse monoclonal (F4)
  • immunocytochemistry; human; 1:25; fig 2i
In order to examine trafficking of cancer-targeting alkylphosphocholine analogues across the blood brain barrier, Invitrogen ABCB1 antibody (Neomarkers, F4) was used in immunocytochemistry on human samples at 1:25 (fig 2i). Mol Pharm (2016) ncbi
mouse monoclonal (UIC2)
  • flow cytometry; human; fig 4
Invitrogen ABCB1 antibody (eBioscience, 17-2439-42) was used in flow cytometry on human samples (fig 4). Stem Cells Int (2016) ncbi
mouse monoclonal (F4)
  • immunocytochemistry; human; 1:25; fig 2
In order to describe methods to differentiate and characterize hPSC-derived brain microvascular endothelial cells, Invitrogen ABCB1 antibody (Thermo Scientific, F4) was used in immunocytochemistry on human samples at 1:25 (fig 2). Methods (2016) ncbi
mouse monoclonal (C219)
  • western blot; pigs ; 1:1000
Invitrogen ABCB1 antibody (Zymed Laboratories, C219) was used in western blot on pigs samples at 1:1000. Biopharm Drug Dispos (2015) ncbi
mouse monoclonal (C219)
  • western blot; human; 1:20
In order to study cord blood as a source of circulating endothelial progenitor cells that can be directed towards specialized endothelial phenotypes, Invitrogen ABCB1 antibody (Thermoscientific, MA1-26528) was used in western blot on human samples at 1:20. PLoS ONE (2014) ncbi
mouse monoclonal (C219)
  • western blot; human
In order to investigate the relationship between PP5/PPP2R3C and P-gp, Invitrogen ABCB1 antibody (Invitrogen, C219) was used in western blot on human samples . Cancer Lett (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR10364-57)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 2a
Abcam ABCB1 antibody (Abcam, ab170904) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2a). Front Endocrinol (Lausanne) (2021) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • immunohistochemistry; human; 1:125; fig 7c
Abcam ABCB1 antibody (Abcam, Ab170904) was used in immunohistochemistry on human samples at 1:125 (fig 7c). Acta Neuropathol Commun (2021) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • western blot; human; loading ...; fig 4c, 6a
Abcam ABCB1 antibody (Abcam, ab170904) was used in western blot on human samples (fig 4c, 6a). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 3c
  • western blot knockout validation; mouse; loading ...; fig 3b
Abcam ABCB1 antibody (AbCam, ab170904) was used in immunohistochemistry knockout validation on mouse samples (fig 3c) and in western blot knockout validation on mouse samples (fig 3b). Neurotrauma Rep (2020) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • immunocytochemistry; human; 1:200; fig 8a
  • western blot; human; 1:2000; fig 8b
  • immunocytochemistry; mouse; 1:200; loading ...; fig 8b
  • western blot; mouse; 1:2000; loading ...; fig 8c
Abcam ABCB1 antibody (Abcam, ab170904) was used in immunocytochemistry on human samples at 1:200 (fig 8a), in western blot on human samples at 1:2000 (fig 8b), in immunocytochemistry on mouse samples at 1:200 (fig 8b) and in western blot on mouse samples at 1:2000 (fig 8c). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • western blot; human; 1:1000; fig s6
Abcam ABCB1 antibody (Abcam, EPR10364-57) was used in western blot on human samples at 1:1000 (fig s6). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • immunocytochemistry; human; fig 1
  • immunocytochemistry; mouse; fig s2
Abcam ABCB1 antibody (Abcam, EPR10364-57) was used in immunocytochemistry on human samples (fig 1) and in immunocytochemistry on mouse samples (fig s2). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • immunohistochemistry; mouse; 1:50; fig 5
Abcam ABCB1 antibody (Abcam, ab170904) was used in immunohistochemistry on mouse samples at 1:50 (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR10364-57)
  • western blot; mouse; 1:500; loading ...; fig 1a,4
Abcam ABCB1 antibody (Abcam, ab170904) was used in western blot on mouse samples at 1:500 (fig 1a,4). Placenta (2015) ncbi
Enzo Life Sciences
mouse monoclonal (C219)
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
  • western blot; human; 1:300; loading ...; fig 2b
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, ALX-801-002-C100) was used in immunocytochemistry on human samples at 1:100 (fig 3a) and in western blot on human samples at 1:300 (fig 2b). Oncol Lett (2018) ncbi
mouse monoclonal (C219)
  • western blot; human; fig 7a
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C219) was used in western blot on human samples (fig 7a). Toxicology (2016) ncbi
mouse monoclonal (C219)
  • immunocytochemistry; mouse; 1:50; fig 3c
Enzo Life Sciences ABCB1 antibody (Alexis, ALX801-002-C100) was used in immunocytochemistry on mouse samples at 1:50 (fig 3c). PLoS ONE (2016) ncbi
mouse monoclonal (C219)
  • western blot; human; loading ...; fig 5b
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C219) was used in western blot on human samples (fig 5b). Mol Pharmacol (2016) ncbi
mouse monoclonal (MRK16)
  • flow cytometry; human; fig 1
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, MRK-16) was used in flow cytometry on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (C219)
  • western blot; domestic sheep; 1:100; loading ...; fig 1
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C219) was used in western blot on domestic sheep samples at 1:100 (fig 1). J Steroid Biochem Mol Biol (2016) ncbi
mouse monoclonal (C219)
  • western blot; human; loading ...; fig 3A
Enzo Life Sciences ABCB1 antibody (ENZO, ALX-801-002-C100) was used in western blot on human samples (fig 3A). Iran J Basic Med Sci (2015) ncbi
mouse monoclonal (C219)
  • immunocytochemistry; human; 1:100
  • western blot; human
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C219) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . Pharm Res (2015) ncbi
mouse monoclonal (C219)
  • western blot; human; 1:250
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, ALX-801-002-C100) was used in western blot on human samples at 1:250. Anticancer Res (2014) ncbi
mouse monoclonal (C219)
  • western blot; mouse
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C219) was used in western blot on mouse samples . Pharm Res (2013) ncbi
mouse monoclonal (C219)
  • western blot; human; 1:200
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C-219) was used in western blot on human samples at 1:200. Antimicrob Agents Chemother (2013) ncbi
mouse monoclonal (C219)
  • immunohistochemistry - paraffin section; mouse; 1:25
Enzo Life Sciences ABCB1 antibody (Enzo Life Sciences, C219) was used in immunohistochemistry - paraffin section on mouse samples at 1:25. Int J Alzheimers Dis (2011) ncbi
mouse monoclonal (JSB-1)
  • immunohistochemistry - paraffin section; human
Enzo Life Sciences ABCB1 antibody (Alexis Biochemicals, JSB-1) was used in immunohistochemistry - paraffin section on human samples . Neurobiol Dis (2010) ncbi
GeneTex
mouse monoclonal (C219)
  • western blot; African green monkey; 1:2500; loading ...; fig 6a
  • western blot; rat; loading ...; fig 6a
GeneTex ABCB1 antibody (GeneTex, GTX23364) was used in western blot on African green monkey samples at 1:2500 (fig 6a) and in western blot on rat samples (fig 6a). Pharmaceutics (2021) ncbi
mouse monoclonal (C219)
  • immunocytochemistry; human; fig 1
  • western blot; human; 1:2000; fig 1
  • immunocytochemistry; mouse; fig s2
  • western blot; mouse; 1:2000; fig s5
GeneTex ABCB1 antibody (GeneTex, GTX23364) was used in immunocytochemistry on human samples (fig 1), in western blot on human samples at 1:2000 (fig 1), in immunocytochemistry on mouse samples (fig s2) and in western blot on mouse samples at 1:2000 (fig s5). J Clin Invest (2016) ncbi
mouse monoclonal (C219)
  • western blot; human; fig 4
GeneTex ABCB1 antibody (GeneTex, GTX23364) was used in western blot on human samples (fig 4). Theranostics (2016) ncbi
mouse monoclonal (C219)
  • western blot; human; loading ...; fig 1a
GeneTex ABCB1 antibody (Gene Tex, C219) was used in western blot on human samples (fig 1a). J Cell Mol Med (2015) ncbi
Novus Biologicals
domestic rabbit monoclonal (SN06-42)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6d
Novus Biologicals ABCB1 antibody (Novus Biologicals, NBP2-67667) was used in immunohistochemistry - frozen section on mouse samples (fig 6d). J Clin Invest (2019) ncbi
OriGene
mouse monoclonal (OTI2F7)
  • western blot; human
OriGene ABCB1 antibody (OriGene, TA801056) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
BioLegend
mouse monoclonal (C494)
  • western blot; human; 1:100; fig s1
BioLegend ABCB1 antibody (Signet Laboratories, C494) was used in western blot on human samples at 1:100 (fig s1). Curr Cancer Drug Targets (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D3H1Q)
  • immunohistochemistry; human; 1:200; loading ...; fig 4c
Cell Signaling Technology ABCB1 antibody (Cell Signaling Technology, 12683) was used in immunohistochemistry on human samples at 1:200 (fig 4c). Science (2020) ncbi
domestic rabbit monoclonal (D3H1Q)
  • western blot; human; loading ...
Cell Signaling Technology ABCB1 antibody (Cell Signaling Technology, 12683) was used in western blot on human samples . Nature (2019) ncbi
domestic rabbit monoclonal (D3H1Q)
  • western blot; human; loading ...; fig s2
Cell Signaling Technology ABCB1 antibody (Cell Signaling, 12683) was used in western blot on human samples (fig s2). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (D3H1Q)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology ABCB1 antibody (Cell Signaling Technologies, 12683) was used in western blot on human samples (fig 5b). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D3H1Q)
  • western blot; human; loading ...; fig 3h
Cell Signaling Technology ABCB1 antibody (Cell Signaling, 12683) was used in western blot on human samples (fig 3h). PLoS ONE (2016) ncbi
Kamiya Biomedical Company
monoclonal (MRK16)
  • flow cytometry; human; loading ...; fig 4a
Kamiya Biomedical Company ABCB1 antibody (Kamiya Biomedical, MC-017) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
BD Biosciences
mouse monoclonal (17F9)
  • flow cytometry; human; loading ...; fig 5e
BD Biosciences ABCB1 antibody (BD Biosciences, 557002) was used in flow cytometry on human samples (fig 5e). Exp Mol Med (2017) ncbi
mouse monoclonal (17F9)
  • flow cytometry; human; tbl 1
BD Biosciences ABCB1 antibody (Becton-Dickinson, 557001) was used in flow cytometry on human samples (tbl 1). Int J Oncol (2016) ncbi
mouse monoclonal (17F9)
  • immunocytochemistry; human; fig 1
  • immunocytochemistry; mouse; fig s2
BD Biosciences ABCB1 antibody (BD Biosciences, 557001) was used in immunocytochemistry on human samples (fig 1) and in immunocytochemistry on mouse samples (fig s2). J Clin Invest (2016) ncbi
mouse monoclonal (17F9)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences ABCB1 antibody (BD, 557003) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (17F9)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences ABCB1 antibody (BD, 17F9) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (17F9)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences ABCB1 antibody (BD Biosciences, 557003) was used in flow cytometry on human samples (fig 5b). Oncotarget (2015) ncbi
mouse monoclonal (17F9)
  • immunocytochemistry; human; 1:100
BD Biosciences ABCB1 antibody (BD Biosciences, 557002) was used in immunocytochemistry on human samples at 1:100. J Biol Chem (2015) ncbi
MilliporeSigma
mouse monoclonal (F4)
  • western blot; human; 1:2000; loading ...; fig 2
MilliporeSigma ABCB1 antibody (Sigma, P7965) was used in western blot on human samples at 1:2000 (fig 2). Sci Rep (2017) ncbi
mouse monoclonal (F4)
  • western blot; human; 1:5000; loading ...; fig 3a
MilliporeSigma ABCB1 antibody (Sigma, P7965) was used in western blot on human samples at 1:5000 (fig 3a). Cell Death Dis (2016) ncbi
mouse monoclonal (F4)
  • immunohistochemistry; human
  • western blot; human
MilliporeSigma ABCB1 antibody (Sigma-Aldrich, P7965) was used in immunohistochemistry on human samples and in western blot on human samples . J Biol Chem (2015) ncbi
Articles Reviewed
  1. Zawatsky C, Park J, Abdalla J, Kunos G, Iyer M, Cinar R. Peripheral Hybrid CB1R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis. Front Endocrinol (Lausanne). 2021;12:744857 pubmed publisher
  2. Watanabe D, Nakagawa S, Morofuji Y, Tóth A, Vastag M, Aruga J, et al. Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes. Pharmaceutics. 2021;13: pubmed publisher
  3. Chung J, Chan M, Tang P, Chan A, Chung J, Meng X, et al. AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF-β/Smad signalling in hepatocellular carcinoma. J Cell Mol Med. 2021;25:9805-9813 pubmed publisher
  4. Waters S, Swanson M, Dieriks B, Zhang Y, Grimsey N, Murray H, et al. Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS. Acta Neuropathol Commun. 2021;9:144 pubmed publisher
  5. Chen M, Zhou J, Wang P, Ye Y, Liu Y, Zhou J, et al. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell. Aging (Albany NY). 2021;13:18310-18330 pubmed publisher
  6. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  7. Vita S, Redell J, Maynard M, Zhao J, Grill R, Dash P, et al. P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury. Neurotrauma Rep. 2020;1:207-217 pubmed publisher
  8. Liu C, He S, Zhang J, Li S, Chen J, Han C. Silencing TCF4 Sensitizes Melanoma Cells to Vemurafenib Through Inhibiting GLUT3-Mediated Glycolysis. Onco Targets Ther. 2020;13:4905-4915 pubmed publisher
  9. Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster M. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science. 2020;: pubmed publisher
  10. Lin A, Parikh I, Yanckello L, White R, Hartz A, Taylor C, et al. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease. Neurobiol Dis. 2020;139:104834 pubmed publisher
  11. Kasendra M, Luc R, Yin J, Manatakis D, Kulkarni G, Lucchesi C, et al. Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model. elife. 2020;9: pubmed publisher
  12. Mercadante C, Prajapati M, Conboy H, Dash M, Herrera C, Pettiglio M, et al. Manganese transporter Slc30a10 controls physiological manganese excretion and toxicity. J Clin Invest. 2019;129:5442-5461 pubmed publisher
  13. Debruyne D, Dries R, Sengupta S, Seruggia D, Gao Y, Sharma B, et al. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. Nature. 2019;572:676-680 pubmed publisher
  14. Yan M, Wang J, Ren Y, Li L, He W, Zhang Y, et al. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. Cell Death Dis. 2019;10:204 pubmed publisher
  15. Weidner L, Kannan P, Mitsios N, Kang S, Hall M, Theodore W, et al. The expression of inflammatory markers and their potential influence on efflux transporters in drug-resistant mesial temporal lobe epilepsy tissue. Epilepsia. 2018;59:1507-1517 pubmed publisher
  16. Mieszala K, Rudewicz M, Gomulkiewicz A, Ratajczak Wielgomas K, Grzegrzolka J, Dziegiel P, et al. Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrol. Oncol Lett. 2018;15:5825-5832 pubmed publisher
  17. Zhang S, Yue Z, Arnold D, Artiushin G, Sehgal A. A Circadian Clock in the Blood-Brain Barrier Regulates Xenobiotic Efflux. Cell. 2018;173:130-139.e10 pubmed publisher
  18. Mrowczynski O, Madhankumar A, Slagle Webb B, Lee S, Zacharia B, Connor J. HFE genotype affects exosome phenotype in cancer. Biochim Biophys Acta Gen Subj. 2017;1861:1921-1928 pubmed publisher
  19. Lian W, Zhang L, Yang L, Chen W. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis. 2017;22:933-941 pubmed publisher
  20. Sekhar G, Georgian A, Sanderson L, Vizcay Barrena G, Brown R, Muresan P, et al. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB). PLoS ONE. 2017;12:e0173474 pubmed publisher
  21. Ito D, Childress M, Mason N, Winter A, O BRIEN T, Henson M, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res. 2015;4:42 pubmed publisher
  22. Lopes Rodrigues V, Di Luca A, Mleczko J, Meleady P, Henry M, Pesic M, et al. Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles. Sci Rep. 2017;7:44541 pubmed publisher
  23. Yang K, Chen Y, To K, Wang F, Li D, Chen L, et al. Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Exp Mol Med. 2017;49:e303 pubmed publisher
  24. Sun X, Duan Z, Liu Z, Tang S, Li Y, He S, et al. Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension. Exp Ther Med. 2016;12:3716-3722 pubmed publisher
  25. Ren H, Liu F, Huang G, Liu Y, Shen J, Zhou P, et al. Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma. Oncotarget. 2017;8:6718-6729 pubmed publisher
  26. Seebacher N, Richardson D, Jansson P. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC. Cell Death Dis. 2016;7:e2510 pubmed publisher
  27. Esser L, Zhou F, Pluchino K, Shiloach J, Ma J, Tang W, et al. Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity. J Biol Chem. 2017;292:446-461 pubmed publisher
  28. Parikh I, Guo J, Chuang K, Zhong Y, Rempe R, Hoffman J, et al. Caloric restriction preserves memory and reduces anxiety of aging mice with early enhancement of neurovascular functions. Aging (Albany NY). 2016;8:2814-2826 pubmed publisher
  29. Zhao X, Li L, Wang X, Fu R, Lv Y, Jin W, et al. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0164752 pubmed publisher
  30. Yang Y, Qiu J, Li Y, Di J, Zhang W, Jiang Q, et al. Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. Am J Transl Res. 2016;8:3986-3994 pubmed
  31. Puvanenthiran S, Essapen S, Seddon A, Modjtahedi H. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs. Int J Oncol. 2016;49:1825-1838 pubmed publisher
  32. Sayyed K, Vee M, Abdel Razzak Z, Jouan E, Stieger B, Denizot C, et al. Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. Toxicology. 2016;363-364:58-71 pubmed publisher
  33. Clark P, Al Ahmad A, Qian T, Zhang R, Wilson H, Weichert J, et al. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm. 2016;13:3341-9 pubmed publisher
  34. Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, et al. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy. Onco Targets Ther. 2016;9:3501-9 pubmed publisher
  35. Han L, Guo X, Bian H, Yang L, Chen Z, Zang W, et al. Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway. Evid Based Complement Alternat Med. 2016;2016:4651949 pubmed publisher
  36. Cederbye C, Palshof J, Hansen T, Duun Henriksen A, Linnemann D, Stenvang J, et al. Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue. Sci Rep. 2016;6:26997 pubmed publisher
  37. Kanda M, Nagai T, Takahashi T, Liu M, Kondou N, Naito A, et al. Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction. PLoS ONE. 2016;11:e0156562 pubmed publisher
  38. Mahdi Z, Synal Hermanns U, Yoker A, Locher K, Stieger B. Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis. Mol Pharmacol. 2016;90:23-34 pubmed publisher
  39. Kim D, Bynoe M. A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier. J Clin Invest. 2016;126:1717-33 pubmed publisher
  40. Aikawa H, Hayashi M, Ryu S, Yamashita M, Ohtsuka N, Nishidate M, et al. Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imaging. Sci Rep. 2016;6:23749 pubmed publisher
  41. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  42. Deng L, Li Q, Lin G, Huang D, Zeng X, Wang X, et al. P-glycoprotein Mediates Postoperative Peritoneal Adhesion Formation by Enhancing Phosphorylation of the Chloride Channel-3. Theranostics. 2016;6:204-18 pubmed publisher
  43. Bhagwandin V, Bishop J, Wright W, Shay J. The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells. PLoS ONE. 2016;11:e0148807 pubmed publisher
  44. Kumar J, Wei B, Madigan J, Simpson R, Hall M, Gottesman M. Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier. Sci Rep. 2016;6:20418 pubmed publisher
  45. Boesch M, Wolf D, Sopper S. Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype. Stem Cells Int. 2016;2016:1652389 pubmed publisher
  46. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  47. Fanelli M, Hattinger C, Vella S, Tavanti E, Michelacci F, Gudeman B, et al. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. Curr Cancer Drug Targets. 2016;16:261-74 pubmed
  48. Stebbins M, Wilson H, Canfield S, Qian T, Palecek S, Shusta E. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods. 2016;101:93-102 pubmed publisher
  49. Liu L, Zhang J, Yang X, Fang C, Xu H, Xi X. SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer. PLoS ONE. 2015;10:e0138515 pubmed publisher
  50. Wilkens M, Maté L, Schnepel N, Klinger S, Muscher Banse A, Ballent M, et al. Influence of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on expression of P-glycoprotein and cytochrome P450 3A in sheep. J Steroid Biochem Mol Biol. 2016;164:271-276 pubmed publisher
  51. Wang C, Li H, Luo C, Li Y, Zhang Y, Yun D, et al. The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure. Placenta. 2015;36:1138-47 pubmed publisher
  52. Wang Y, Wu K, Yang Z, Zhao Q, Fan D, Xu P, et al. Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer. PLoS ONE. 2015;10:e0135461 pubmed publisher
  53. Ayadi M, Bouygues A, Ouaret D, Ferrand N, Chouaib S, Thiery J, et al. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors. Oncotarget. 2015;6:18518-33 pubmed
  54. Bosco D, Kenworthy R, Zorio D, Sang Q. Human mesenchymal stem cells are resistant to Paclitaxel by adopting a non-proliferative fibroblastic state. PLoS ONE. 2015;10:e0128511 pubmed publisher
  55. Nourbakhsh M, Jaafari M, Lage H, Abnous K, Mosaffa F, Badiee A, et al. Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer. Iran J Basic Med Sci. 2015;18:385-92 pubmed
  56. Bernd A, Ott M, Ishikawa H, Schroten H, Schwerk C, Fricker G. Characterization of efflux transport proteins of the human choroid plexus papilloma cell line HIBCPP, a functional in vitro model of the blood-cerebrospinal fluid barrier. Pharm Res. 2015;32:2973-82 pubmed publisher
  57. Qiu J, Zhang Y, Li Y, Zhao J, Zhang W, Jiang Q, et al. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget. 2015;6:15494-509 pubmed
  58. Hung T, Li Y, Tseng C, Lan Y, Hsu S, Chen Y, et al. Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines. Cancer Gene Ther. 2015;22:262-70 pubmed publisher
  59. Zhao W, Chen R, Zhao M, Li L, Fan L, Che X. High glucose promotes gastric cancer chemoresistance in vivo and in vitro. Mol Med Rep. 2015;12:843-50 pubmed publisher
  60. Jansson P, Yamagishi T, Arvind A, Seebacher N, Gutierrez E, Stacy A, et al. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp). J Biol Chem. 2015;290:9588-603 pubmed publisher
  61. Fantappiè O, Sassoli C, Tani A, Nosi D, Marchetti S, Formigli L, et al. Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane. J Cell Mol Med. 2015;19:1410-7 pubmed publisher
  62. Loganzo F, Tan X, Sung M, Jin G, Myers J, Melamud E, et al. Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments. Mol Cancer Ther. 2015;14:952-63 pubmed publisher
  63. Chong K, Hsu C, Hung T, Hu H, Huang T, Wang T, et al. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther. 2015;16:149-59 pubmed publisher
  64. Ma H, Yue X, Gao L, Liang X, Yan W, Zhang Z, et al. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA. Oncotarget. 2015;6:1049-63 pubmed
  65. Hasibu I, Patoine D, Pilote S, Drolet B, Simard C. The guinea-pig expresses functional CYP2C and P-glycoprotein: further validation of its usefulness in drug biotransformation/transport studies. Biopharm Drug Dispos. 2015;36:183-203 pubmed publisher
  66. Hung T, Hsu S, Cheng C, Choo K, Tseng C, Chen T, et al. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014;5:12273-90 pubmed
  67. Wang C, Zhang W, Fu M, Yang A, Huang H, Xie J. Establishment of human pancreatic cancer gemcitabine‑resistant cell line with ribonucleotide reductase overexpression. Oncol Rep. 2015;33:383-90 pubmed publisher
  68. Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, et al. NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma. Oncotarget. 2014;5:11986-97 pubmed
  69. Salomon J, Muchitsch V, Gausterer J, Schwagerus E, Huwer H, Daum N, et al. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier. Mol Pharm. 2014;11:995-1006 pubmed publisher
  70. Doherty B, Lawlor D, Gillet J, Gottesman M, O Leary J, Stordal B. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells. Anticancer Res. 2014;34:503-7 pubmed
  71. Boyer Di Ponio J, El Ayoubi F, Glacial F, Ganeshamoorthy K, Driancourt C, Godet M, et al. Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes. PLoS ONE. 2014;9:e84179 pubmed publisher
  72. Liu X, Chen L, Feng B, Liu G. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma. Anat Rec (Hoboken). 2014;297:215-21 pubmed publisher
  73. Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y. Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014;345:124-31 pubmed publisher
  74. Aleksunes L, Xu J, Lin E, Wen X, Goedken M, Slitt A. Pregnancy represses induction of efflux transporters in livers of type I diabetic mice. Pharm Res. 2013;30:2209-20 pubmed publisher
  75. Vinot C, Gavard L, Treluyer J, Manceau S, Courbon E, Scherrmann J, et al. Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression. Antimicrob Agents Chemother. 2013;57:1415-20 pubmed publisher
  76. Brenn A, Grube M, Peters M, Fischer A, Jedlitschky G, Kroemer H, et al. Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice. Int J Alzheimers Dis. 2011;2011:690121 pubmed publisher
  77. Kwan P, Li H, Al Jufairi E, Abdulla R, Gonzales M, Kaye A, et al. Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsy. Neurobiol Dis. 2010;39:192-7 pubmed publisher